A carregar...
PD-L1 mAb Treats Ischemic Stroke by Controlling CNS Inflammation
BACKGROUND AND PURPOSE: Both pathogenic and regulatory immune processes are involved in the middle cerebral artery occlusion (MCAO) model of experimental stroke, including interactions involving the Programmed Death 1 (PD-1) receptor and its two ligands, PD-L1 and PD-L2. Although PD-1 reduced stroke...
Na minha lista:
| Publicado no: | Stroke |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589506/ https://ncbi.nlm.nih.gov/pubmed/26306753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.115.010592 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|